Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ángela Quintana"'
Autor:
Paulina Czajka-Francuz, Maria J. Prendes, Arun Mankan, Ángela Quintana, Sarabjot Pabla, Shakti Ramkissoon, Taylor J. Jensen, Sandra Peiró, Eric A. Severson, Bhagelu R. Achyut, Laura Vidal, Martine Poelman, Kamal S. Saini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The efficacy of cancer therapies is limited to a great extent by immunosuppressive mechanisms within the tumor microenvironment (TME). Numerous immune escape mechanisms have been identified. These include not only processes associated with tumor, imm
Externí odkaz:
https://doaj.org/article/c983bc8e853a4c678767f1d5a192568b
Autor:
Ángela Quintana, Enrique Javier Arenas, Cristina Bernadó, José Fernández Navarro, Jonatan González, Anna Esteve-Codina, Teresa Moliné, Merce Marti, Giuseppe Curigliano, Peter Schmid, Vicente Peg, Joaquín Arribas, Javier Cortés
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTumor infiltrating lymphocytes (TILs) are known to be a prognostic and predictive biomarker in breast cancer, particularly in triple negative breast cancer (TNBC) patients. International guidelines have been proposed to evaluate them in t
Externí odkaz:
https://doaj.org/article/b12b9107a3c848078a4ede6efaf4d2df
Autor:
Kamal S. Saini, Sasikala Somara, Heidi C. Ko, Purva Thatai, Angela Quintana, Zachary D. Wallen, Michelle F. Green, Ravi Mehrotra, Sandra McGuigan, Lingjuan Pang, Soma Das, Kavita Yadav, Dobrica Neric, Luca Cantini, Chinmayee Joshi, Kazuya Iwamoto, Sudha Dubbewar, Laura Vidal, Isagani Chico, Eric Severson, Luigi Lorini, Sunil Badve, Paolo Bossi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Recent strides in understanding the molecular underpinnings of head and neck cancers have sparked considerable interest in identifying precise biomarkers that can enhance prognostication and enable personalized treatment strategies. Immunotherapy has
Externí odkaz:
https://doaj.org/article/402cb59d0e0442be82309e8f45d3d0e6
Autor:
Idoko Salifu, Navneet Singh, Maria Berraondo, Jordi Remon, Stephanie Salifu, Eric Severson, Angela Quintana, Sandra Peiró, Shakti Ramkissoon, Laura Vidal, Isagani Chico, Kamal S. Saini
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100713- (2023)
Introduction: Advanced non-small cell lung cancer (aNSCLC) is an incurable disease. The effort to develop treatments with more effective systemic agents continues. This has led to the FDA approval of one antibody–drug conjugate (ADC) and eight immu
Externí odkaz:
https://doaj.org/article/f0c24e34428c42d1adf674ebc5a07d72